RANDEEP Singh

Head Medical oncology @ Narayana Health , Delhi NCR .Director Oncomed Clinic Delhi .

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

The ethics editorial argues that equitable immunotherapy access in India requires evidence-based use of high-value regimens, low-dose science, indigenous innovation, and policy reforms so that precision oncology and affordability advance together.

https://t.co/Vqch7vx6c7

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

The head-and-neck cancer treatment review finds that both neoadjuvant chemo followed by surgery and definitiveCRT are curative options, with CRT remaining the mainstay while neoadjuvant chemotherapy is particularly valuable for downstaging prior to Sx

https://t.co/okfF52WXSh

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

The immune checkpoint inhibitor review concludes that ICIs have reshaped outcomes in recurrent/metastatic HNSCC offering durable responses for a subset of patients but demanding biomarker-driven selection to overcome resistance, &financial burden

https://t.co/XyUQ7getJs

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

New in IJMIO: An editorial on the ethics of immunotherapy access, Review on immune checkpoint inhibitors in recurrent/metastatic H&N SCC, a comparative review of neoadjuvant chemo plus surgery vS definitive chemoradiotherapy in locally advanced head-and-neck cancer—now online

[OncoAlert @OncoAlert]

Dear Colleagues
Coming 1⃣st Week of February 2026:
The 6th Annual OncoAlert Colloquium 🚨
REGISTER👉 https://t.co/UFHVgGdeKx

Our Faculty List Keeps on Growing and
As ALWAYS ✅Patients Included

#BreastCancer
@hoperugo🇺🇸
@matteolambe🇮🇹
@Icro_Meattini🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@E_de_Azambuja 🇧🇪
@itrisabel🇪🇸 ESSO
@ElisaAgostinett 🇧🇪
Dr. Fatima Cardoso 🇵🇹 @ABCGlobalAll
@LazarPo31787807 🇷🇸

#LungCancer
@GlopesMd🇺🇸
@jillfeldman4 @EGFRResisters🇺🇸
@UmbertoMalapel1 🇮🇹 @isliquidbiopsy
@BRicciutiMD 🇺🇸
@UOzkerim 🇹🇷

GU Oncology
@brian_rini @Uromigos🇺🇸
@declangmurphy @gu_onc🇦🇺
@KidneyCancer🇺🇸
@APCCC_Lugano🇨🇭
@RenuEapen🇦🇺
@nataliagandur 🇦🇷
@seanmcbride 🇺🇸

GI Oncology
@BenWestphalen 🇩🇪
@CathyEngMD 🇺🇸
@florianlordick 🇩🇪
@NiuSanford 🇺🇸
@realbowtiedoc 🇺🇸
@ARosen380 🇺🇸
@Erman_Akkus 🇹🇷

Melanoma
@DrBetofMDPhD 🇺🇸

Our Partners
@ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg

Our Collaborators
APCCC, GU CAST, @Uromigos and more
and more to come.......

#OncoAlertAF
@HHorinouchi @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @MarioBalsaMD @DrMirallas @GIMedOnc @DrRishabhOnco @Onco_Cifu88 @PaulJiL

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

🚨 New Issue Alert!
The International Journal of Molecular and Immuno Oncology (IJMIO) Volume 10, Issue 2 (May–Aug 2025) is now published online. Explore cutting-edge work in molecular oncology, immunotherapy, and translational research: https://t.co/2AE9XiRInP

[RANDEEP Singh @OncomedR]

@SuyogCancer Maximum experience with Atezo and Bev and best tolerability amongst the given combination choices .

[Uday Yanamandra @UdayYanamandra]

@bagalbp @myelomaMD @DrPMPGI @Aditya_PGI @DrNikitaMehra @lingarajnayak

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

"Exciting progress in cancer care in India”@Prasshmehta & @QuantumOnc highlight key steps in the right direction to improve treatment and access.
A must-read for anyone following advancements in cancer
#CancerCare #India #HealthcareInnovation #Oncology
https://t.co/Bd5uddKWk4

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

This is an important milestone, ensuring the journal is aligned with the standards required for academic credibility.
The EMBASE coverage will start from Janउआर्य 2025 onward, ensuring that all articles published from this date will be available in the database @QuantumOnc

[Nikita Poojary @niki_poojary]

@RijhwaniSheetal Hey Sheetal nice thread on the checkpoints to watch for when markets are at ATH.👍

The explanation with charts especially BO /BD with retest is really useful. 👌

Awesome thread 👏

[RANDEEP Singh @OncomedR]

@AnantRamaswamy @CSMIA_Official Akin to luggage belt number announcement at aircraft arrival , the crew can announce that buggi service is available for elderly and frail . The ground staff has to be senstized for the same and be pro active in arranging buggy whenever they see elderly frail traveller

[Dr (Prof). Vijay Patil @DrVijayPatil11]

Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert https://t.co/XcE2tt8FRV

[Prof. Anil D'Cruz @docdcruz]

As an oncologist having seen suffering for over 30 years 🙏🙏🙏

[RANDEEP Singh @OncomedR]

@drakhilkapoor1 @ravikanesvaran @myESMO @TMC_Varanasi @VanitaNoronha @JyotiBajpai01 @ISMPOofficial Congrats Akhil , well deserved

[RANDEEP Singh @OncomedR]

@DrVijayPatil11 @Bhosale26Bharat @CMOMaharashtra @ashayoncology @VikasO @bagalbp @Amolpatel_dr @SuyogCancer होनहार बिरबान के होत चिकने पात

[International Journal Molecular @ Immuno Oncology @IjmioJournal]

Please read the Ahead of Print articles published by IJMIO at @OncomedR @purvish1 @DrRadhikaV @scientifscholar
https://t.co/tWnXIU0Qhd

[Bharat @Bhosale26Bharat]

Inauguration of chemotherapy day care@Borivali . This day care is supported by Tata hospital and Nana palkar Smruti Samiti . And sunrise oncology team will look after the patient care services.⁦⁦@tmhmedoncalumni⁩

[Bharat @Bhosale26Bharat]

On auspicious occasion of Navaratri important MOU between TMH and Nana Palkar Smruti Samiti.Cancer patients will get benefited in western suburbs of Mumbai with starting 1st chemo day care in collaboration with Sunrise Onco centre Borivali.⁩⁦@TataMemorial⁩⁦

[RANDEEP Singh @OncomedR]

@sajconline @Scopus @purvish1 @dr_hingmire @VanitaNoronha @drshweta_pedonc @sujithonco @ThiemeNY Congrats to the team